US Patent Issued to Dompe' Farmaceutici on June 23 for "Nerve growth factor and methods of use thereof for neurodevelopmental disabilities associated with neonatal hypoxic-ischemic encephalopathy" (Italian Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,519, issued on June 23, was assigned to Dompe' Farmaceutici S.P.A. (Milan).

"Nerve growth factor and methods of use thereof for neurodevelopmental disabilities associated with neonatal hypoxic-ischemic encephalopathy" was invented by Andrea Aramini (L{grave over ( )}Aquila, Italy), Laura Brandolini (L{grave over ( )}Aquila, Italy), Serena Boccella (Naples, Italy) and Rubina Novelli (L{grave over ( )}Aquila, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to nerve growth factor (NGF) for use in the prevention or treatment of neurodevelopmental disabilities associated with neonatal hypoxic-ischemic encephalopathy in...